Press release
Pneumonia Therapeutics Market Growing to Exhibit a Striking Growth with CAGR of 8.1% by 2030, Size, Share, Trends, Competitive Scenario and Industry Growth Analysis
Pneumonia Therapeutics Market survey report includes the most important market insights that progress the business to the next level of growth and success. The market factors can be listed as; emerging trends, product usage, motivating factors for customers and competitors, market restraints, brand positioning, and customer behaviour. In market document, industry trends are put together on macro level which helps businesses understand market landscape and possible future issues. Market parameters covered in the best Pneumonia Therapeutics Market report mainly range from market definition, currency and pricing, market segmentation, market overview, premium insights, key insights to company profile of the key market players.
Data Bridge Market Research analyses a growth rate in the pneumonia therapeutics market in the forecast period 2023-2030. The expected CAGR of hypophosphatemia treatment market is around 8.1% in the mentioned forecast period. The market was valued at USD 2.15 billion in 2022, and it would grow upto USD 4 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Visit full Study Report @ https://www.databridgemarketresearch.com/reports/global-pneumonia-therapeutics-market
Pneumonia is an inflammatory medical condition that affects the air sacs and alveoli in the lungs. Pathogens such as bacteria, virus and fungi are causing the pneumococcal infection through inhalation of air borne droplets from sneeze or cough. It can also be caused by contact with objects and surfaces contaminated with pneumonia causing bacteria and virus. According to WHO, the annual incidence is around 150.7 million cases, of which 7% to 13% require intensive treatment.
Global Pneumonia Therapeutics Market Dynamics
Drivers
Rising Demand of Antiviral Drugs
Viral pneumonia spreads through fluid present in the air droplets after an individual coughs or sneezes. These fluids enter into the body through mouth or nose. Numerous treatment options such as oseltamivir and acyclovir among others are used to treat the antiviral infection. Likewise, these drugs help reduce the severity of flu virus spreading into the body, further enhancing the market progression. Thus, the more and more consumption of antiviral drugs acts as a major driver of growth in the global pneumonia therapeutics market.
Growing number of hospital-acquired pneumonia infections
Hospital-acquired pneumonia is a lung infection which occurs during hospital stays. Majority of patients with hospital-acquired pneumonia develop severe complications that include renal failure, respiratory failure and empyema because of severe and weak health conditions. Thus, increasing occurrences of hospital-acquired pneumonia will increase the demand for pneumonia therapeutics drugs.
Key players operating in the pneumonia therapeutics market include:
AstraZeneca (U.K.)
Lilly (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
Novartis AG (Switzerland)
Sun Pharmaceutical Industries Ltd. (India)
Aurobindo Pharma (India)
Lupin (India)
Merck & Co., Inc. (U.S.)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
Hikma Pharmaceuticals PLC (U.K.)
Cipla Inc. (India)
Lupin (India)
Recent Development
In June 2019, Merck received FDA approval for the Zerbaxa drug used to treat ventilator-associated pneumonia and hospital-acquired bacterial pneumonia. This strategy expanded the firm's pneumonia therapeutics portfolio.
Global Pneumonia Therapeutics Market Scope
The pneumonia therapeutics market is segmented on the basis of drug class, age group, type, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug Class
Antibacterial Drugs
Macrolide
Quinolones
Antiviral Drugs
Oseltamivir phosphate
Zanamivir
Antifungal Drugs
Clotrimazole
Econazole
Age Group
Paediatric
Adult
Geriatric
Infection Type
Hospital-acquired Pneumonia [HAP]
Community-acquired Pneumonia [CAP]
Ventilator-associated Pneumonia [VAP]
Type
Drugs
Preventive Vaccines
Oxygen Therapy
Route of Administration
Oral
Parenteral
Others
End User
Hospitals
Homecare
Specialty Clinics
Others
Distribution Channel
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
This Market Intelligence Report Analyses Some of the Most Crucial Concerns:
• How will the major segments of this international market develop over the next few years?
• Who are the major players that will dominate the market in the future?
• When it comes to this industry, who are the top suppliers and producers?
• How have the most successful companies in the industry planned for future growth and expansion?
• In what sectors might we expect to see the greatest increase in demand over the coming years?
• How many distinct subsets of buyers make up this Pneumonia Therapeutics Market?
• Which regional powerhouse do you foresee as becoming the largest player in the international market?
• Does a new coronavirus pandemic have any consequences?
• In what ways are established actors stymied by the entry of newcomers, and how may they be overcome?
Browse More Reports
https://markettreports.blogspot.com/2023/09/europe-lung-cancer-diagnostics-market.html
https://markettreports.blogspot.com/2023/09/north-america-ambulatory-x-ray-devices.html
https://markettreports.blogspot.com/2023/09/gene-therapy-market-trends-share.html
https://markettreports.blogspot.com/2023/09/digital-therapeutics-market-industry.html
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - corporatesales@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pneumonia Therapeutics Market Growing to Exhibit a Striking Growth with CAGR of 8.1% by 2030, Size, Share, Trends, Competitive Scenario and Industry Growth Analysis here
News-ID: 3205233 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Pneumonia
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776
Key Market Drivers
• Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market?
The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
